Parallax Volatility Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parallax Volatility Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,019	Closed	-$2.08M	–	2626
2023 Q3	$2.08M	Sell	18,019 -1,410	-7%	-$152K	﹤0.01%	1077
2023 Q2	$2M	Buy	19,429 +8,918	+85%	+$941K	﹤0.01%	1137
2023 Q1	$1.15M	Buy	+10,511	New	+$1.16M	﹤0.01%	1442
2022 Q4	–	Sell	-11,356	Closed	-$943K	–	3515
2022 Q3	$703K	Buy	+11,356	New	+$793K	﹤0.01%	1866
2022 Q2	–	Sell	-2,057	Closed	-$195K	–	3524
2022 Q1	$216K	Buy	2,057 +650	+46%	+$63.3K	﹤0.01%	2160
2021 Q4	$152K	Sell	1,407 -7,099	-83%	-$774K	﹤0.01%	2528
2021 Q3	$932K	Buy	8,506 +6,227	+273%	+$646K	﹤0.01%	1999
2021 Q2	$213K	Sell	2,279 -7,184	-76%	-$661K	﹤0.01%	2445
2021 Q1	$871K	Buy	9,463 +6,653	+237%	+$561K	﹤0.01%	2143
2020 Q4	$206K	Buy	2,810 +2,391	+571%	+$178K	﹤0.01%	2773
2020 Q3	$33K	Buy	+419	New	+$28.8K	﹤0.01%	2899
2019 Q2	–	Sell	-6,100	Closed	-$161K	–	4210
2019 Q1	$161K	Buy	6,100 +6,053	+12,879%	+$143K	﹤0.01%	1971
2018 Q4	$1K	Buy	+47	New	+$921	﹤0.01%	2832
2018 Q1	–	Sell	-24,822	Closed	-$362K	–	5114
2017 Q4	$362K	Buy	+24,822	New	+$349K	﹤0.01%	1766
2016 Q1	–	Sell	-13,967	Closed	-$303K	–	4129
2015 Q4	$303K	Sell	13,967 -18,342	-57%	-$357K	﹤0.01%	1734
2015 Q3	$640K	Buy	+32,309	New	+$1.02M	﹤0.01%	1445

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Parallax Volatility Advisers's HZNP Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 18,019 shares — an estimated $2.08M sold.

Parallax Volatility Advisers first reported a position in HZNP in Q3 2015 and held it in 16 quarters. The position peaked at $2.08M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Parallax Volatility Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 18,019 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.08M.
Parallax Volatility Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 16 quarters.
Parallax Volatility Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.08M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.